Talking therapy could help thalassemia patients take their meds

NCT ID NCT07660224

Not yet recruiting Symptom relief Sponsor: Oman Ministry of Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether motivational interviewing, a type of counseling, can help adults with beta-thalassemia major follow their iron chelation therapy more consistently. Forty-five participants in Oman will receive three one-on-one sessions with a nurse over six to eight weeks. Researchers will measure adherence, self-confidence, and blood iron levels before and after the sessions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: motivational interviewing
What this could lead to: If it works, this could offer a simple, drug-free way to help people with thalassemia stick to their iron chelation therapy, reducing complications.
What could go wrong: This is a very small, early study with no control group, so results may not be reliable or apply to others. The benefit may be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BETA-THALASSEMIA MAJOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

beta thalassemia beta-thalassemia major thalassemia Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BETA-THALASSEMIA MAJOR TRANSFUSION-DEPENDENT THALASSEMIA

More trials for these conditions

Other studies related to the condition(s) this trial covers.